Calluna Pharma AS (Calluna), a clinical stage biotechnology company pioneering first-in-class antibodies to treat ...

BOSTON, April 28, 2025--nChroma Bio ("nChroma"), a genetic medicines company advancing programmable in vivo delivery to overcome the limitations of existing therapies, today announced the acceptance ...

WALTHAM, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- ElevateBio, a technology-driven company focused on powering the creation of life-transforming genetic medicines, today announced presentations at the ...

SEATTLE, April 28, 2025 (GLOBE NEWSWIRE) -- Shape Therapeutics, a leader in RNA-based gene therapy, today announced the acceptance of multiple abstracts, including two oral presentations, at the ...

Palvella Therapeutics, Inc. (Nasdaq: PVLA) announced that an abstract presenting groundbreaking data on the prevalence and ...

Neurosurgery experts from UCSF Health will present new research and clinical findings at the American Association of Neurological Surgeons (AANS) Annual Scientific Meeting in Boston, April 25-28.

More than 100 Alfred University students participated in the 2025 Undergraduate Research Forum, held Thursday, April 24, in ...

Alfred University senior Emma Suplicki has a lifelong love for horses. The political science major from East Concord, NY, ...

BioAtla (BCAB) announced preclinical poster presentations at the upcoming 2025 American Association for Cancer Research to be held at the ...

A copy of the presentation materials can be accessed on the “ Publication ” section of the Company’s website at www.bioatla.com once the presentations have concluded.